GDF invites applications for twenty-sixth round of grants
28 November 2011 - Geneva - The Stop TB Partnership's Global Drug Facility (GDF) is inviting applications for its twenty-sixth round of grants.
Applications from governments for grants of first-line adult and paediatric anti-tuberculosis drugs will be accepted between 29 November and 23 January 2012.
"Our ultimate reason to exist as the Stop TB Partnership is to make sure that people suffering from TB are diagnosed, placed on treatment and cured. It's as simple as that," said Lucica Ditiu, Executive Secretary of the Stop TB Partnership. "However, this is not an easy task and access to quality-assured anti-TB drugs remains, in spite of all the efforts, a challenge.
"In these times of significant financial constraints, we call upon countries and programmes to make realistic, but bold assessments on what their needs are in terms of treatments and map the available resources - including domestic ones - to these needs. Then, be bold and vocal to ensure that all patients will have the drugs and access to the right treatment and care," Dr Ditiu said.
For full details on how to apply please read the full announcement on the GDF website. Information is currently available in English and will be available in French and Spanish shortly.
GDF's grant service provides quality-assured adult and pediatric first-line anti-TB drugs to countries who lack adequate resources and procurement capacity, via grants which are approved by a technical review committee (TRC).
Read the GDF announcement in full
The Stop TB Partnership
